Laure Marignol,Henning Willers
Laure Marignol
α/β for Hepatocellular Carcinoma Tumors Treated with Radiation Therapy [0.03%]
放射治疗的 hepatocellular carcinoma 肿瘤的 α/β值分析
Lise Wei,Yaxuan Huang,Randall K Ten Haken et al.
Lise Wei et al.
Purpose: Primary Hepatocellular Carcinoma (HCC) lesions are frequently treated with fractionated radiation therapy. The linear-quadratic (LQ) model can be used to compare different fractionation schemes for their effect o...
Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy [0.03%]
端粒长度动力学作为个体放射敏感性和胸部放疗肺癌患者肺炎的生物标志物
Ting Zhai,Sneh M Toprani,Maeve Dillon-Martin et al.
Ting Zhai et al.
Background: Telomere shortening is a biomarker for genome instability and aging, and the vulnerability of telomeric DNA to oxidative damage suggests its potential role in mediating radiotherapy (RT) side effects. This stu...
Long-term outcomes of Stereotactic MRI-guided adaptive radiotherapy (SMART) for prostate cancer: Results from a real world large patient cohort [0.03%]
立体定向磁共振引导自适应放射治疗（SMART）治疗前列腺癌的长期疗效分析：一项大规模真实世界人群研究结果
Claire van Vliet,Shyama U Tetar,Omar Bohoudi et al.
Claire van Vliet et al.
Purpose: Stereotactic MRI-guided adaptive radiotherapy (SMART) has emerged as a treatment for localized prostate cancer with excellent acute toxicity outcomes. However, long-term outcomes have not been reported. This stud...
Rohann J M Correa,Muhammad Ali,Vivian S Tan et al.
Rohann J M Correa et al.
Stereotactic ablative radiotherapy (SABR), or stereotactic body radiotherapy (SBRT), has emerged as a new standard of care treatment option for localized renal cell carcinoma {RCC). Here we present an accessible, high-yield guide to impleme...
Acute Toxicity and Cosmesis Following a Tumor Bed Boost After Whole Breast Moderate Dose Hypofractionation [0.03%]
全乳腺中剂量调强放疗后肿瘤区域补量的急性毒性及美容效果
Michael Dykstra,Kent Griffith,Alexander Moncion et al.
Michael Dykstra et al.
Purpose: Randomized evidence suggests tumor bed boost improves local control following whole breast radiotherapy (WBRT) but may lead to more acute and late toxicity. However, little data is available about toxicity in rea...
Curietherapy User eXperience pilot study (CurieUx): a feasibility study of a novel augmented reality educational tool during radiation oncology consultation for patients with breast cancer [0.03%]
用于乳腺癌放射治疗的新型增强现实教育工具可行性研究
David J Byun,Elisa K Liu,Olivier Maisonet et al.
David J Byun et al.
Purpose: Improved communication by clinicians at initial consultation may reduce anxiety and psychological burden of cancer treatment. Based on our pilot qualitative study which involved semi-structured interviews with br...
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort [0.03%]
立体定向体部放射治疗中心肺肿瘤后致死性支气管肺出血的剂量体积预测因素：HILUS队列扩展分析
Kristin Karlsson,Tiziana Rancati,Elias Lindbäck et al.
Kristin Karlsson et al.
Purpose: The expanded HILUS study showed that bronchial dose and bronchial tumor compression are risk factors for bronchopulmonary bleedings after stereotactic body radiation therapy of centrally located lung tumors. In t...
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer [0.03%]
SPARC二期临床试验的2年结果：立体定向放疗同时局灶增强治疗局部中高危前列腺癌
Binnaz Yasar,Yae-Eun Suh,Ewan Chapman et al.
Binnaz Yasar et al.
Purpose: Stereotactic body radiotherapy (SBRT) with focal boost to the dominant intraprostatic lesion (DIL) provides a strategy to enhance outcomes in high-risk localised prostate cancer while minimising toxicity. This st...
Four-year Feasibility and Safety Results of a Phase I/II Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART) for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases [0.03%]
分阶段I/II单臂前瞻性临床试验4年可行性及安全性结果：立体定向磁共振引导适应性放射治疗(SMART)治疗异时寡转移腹膜后淋巴结和软组织转移病灶
Thomas P Howard,Tyler Walburn,Grant Benham et al.
Thomas P Howard et al.
Purpose/objectives: Metachronous oligometastases may represent a favorable disease state for local therapy after prior curative treatment. Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART) provides...